首页 | 本学科首页   官方微博 | 高级检索  
     


Gene expression profiles in an hepatitis B virus transfected hepatoblastoma cell line and differentially regulated gene expression by interferon-α
Authors:Xun Wang  Zheng-Hong Yuan  Ling-Jie Zheng  Feng Yu  Wei xiong  Jiang-Xia Liu  Gen-Xi Hu  Yao Li
Abstract:AIM: To study interactions between hepatitis B virus (HBV)and interferon-α in liver- derived cells.METHODS: mRNAs were separately isolated from an HBVtransfected cell line (HepG22.2.15) and its parental cell line (HepG2) pre- and post-interferon-α (IFN-α) treatment at 6,24 and 48 h, followed by hybridization with a cDNA microarray filter dotted with 14 000 human genes. After hybridization and scanning of the arrays, the data were analyzed using ArrayGauge software. The microarray data were further verified by Northern blot analysis.RESULTS: Compared to HepG2 cells, 14 genes with known functions were down-regulated 3 to 12- magnitudes, while 7genes were up-regulated 3-13 magnitudes in HepG22.2.15cells prior to IFN-α treatment. After interferon-α treatment,the expression of four genes (vascular endothelial growth factor, tyrosine phosphate 1E, serine protein with IGF-binding motif and one gene of clathrin light chain) in HepG22.2.15were up-regulated, while one gene encoding a GTP-binding protein, two genes of interferon-induced kinases and two proto-oncogenes were further down- regulated. Interestingly,under IFN-α treatment, a number of differentially regulated genes were new ESTs or genes with unknown functions.CONCLUSION: The up-regulated genes in HepG22.2.15cell line suggested that under IFN-α treatment, these repressed cellular genes in HBV infected hepatocytes could be partially restored, while the down- regulated genes were most likely the cellular genes which could not be restored under interferon treatment. These down-regulated genes identified by microarray analysis could serve as new targets for anti-HBV drug development or for novel therapies.
Keywords:
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号